Nutex Health, Inc.

Nutex Health, Inc.

NUTX

$208.82

Updated: 23/09/2026, 07:04:13

Market Cap
$1.44B
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Stock valuation chart
One-year closing share-price history for NUTX
Company Profile

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.

USD
NASDAQ
CEO: Thomas T. Vo
Employees: 1,037
https://www.nutexhealth.com
Asset Summaries
Latest generated summaries for NUTX

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for NUTX.
Share price
$208.82
Market cap
$1.44B
Exchange
NASDAQ
Currency
USD
CEO
Thomas T. Vo
Employees
1,037
IPO date
04/04/2022
Beta
2.024
Last dividend
$0.00
Day range
$201.92 – $212.10
52-week range
$83.99 – $224.28
1-day performance
3.64%
1-year performance
148.62%
Current drawdown (1Y)
-6.89%
CIK
0001479681
CUSIP
67079U306
ISIN
US67079U3068
Created
07/12/2025, 05:31:48
Last update
23/09/2026, 07:04:13

Track Nutex Health, Inc. with an AI analyst

See which prediction-market events move NUTX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to NUTX from your Railway `news_articles` table.

Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm

GlobeNewsWire • STOCK • 09/06/2026, 19:13:00

Nutex Health Inc. (NUTX) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 01/05/2026, 15:51:34

NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

PRNewsWire • STOCK • 30/04/2026, 19:15:00

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX

GlobeNewsWire • STOCK • 17/03/2026, 18:11:00

Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm

GlobeNewsWire • STOCK • 13/03/2026, 14:38:00

Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

GlobeNewsWire • STOCK • 13/03/2026, 12:41:00

Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

GlobeNewsWire • STOCK • 10/03/2026, 14:52:00

Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 06/03/2026, 18:45:57

INVESTOR ALERT: Investigation of Nutex Health, Inc. (NUTX) announced by Holzer & Holzer, LLC

GlobeNewsWire • STOCK • 06/03/2026, 17:09:00

NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM

PRNewsWire • STOCK • 05/03/2026, 19:33:00

Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet

Seeking Alpha • STOCK • 26/02/2026, 09:19:33

Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

PRNewsWire • STOCK • 25/02/2026, 18:29:00